Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-11-08 07:06 am Purchase |
2023-11-06 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 95,561,160 13.630% |
2,188,575![]() (+2.34%) |
Filing History |
2023-11-06 07:30 am Purchase |
2023-11-03 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 93,372,585 13.320% |
1,081,380![]() (+1.17%) |
Filing History |
2023-11-02 07:30 am Purchase |
2023-10-31 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 92,291,205 13.250% |
92,130![]() (+0.10%) |
Filing History |
2023-10-30 6:02 pm Purchase |
2023-10-27 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 92,199,075 13.150% |
2,168,475![]() (+2.41%) |
Filing History |
2023-08-10 4:42 pm Sale |
2023-07-31 | 13G | Mereo BioPharma Group plc MREO |
Baker Bros. Advisors LP | 14,604,391 2.200% |
-54,754,968![]() (-78.94%) |
Filing History |
2023-07-26 4:31 pm Purchase |
2023-07-24 | 13G | Mereo BioPharma Group plc MREO |
Soleus Private Equity Fund III L.P. | 48,387,095 7.500% |
48,387,095![]() (New Position) |
Filing History |
2023-06-16 08:00 am Purchase |
2023-06-14 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 90,030,600 14.410% |
6,250,000![]() (+7.46%) |
Filing History |
2023-02-14 4:40 pm Purchase |
2022-12-31 | 13G | Mereo BioPharma Group plc MREO |
ORBIMED ADVISORS LLC | 10,378,591 5.920% |
4,315,246![]() (+71.17%) |
Filing History |
2023-02-14 4:03 pm Sale |
2022-12-31 | 13G | Mereo BioPharma Group plc MREO |
Point72 Asset Management, L.P. | 22 0.100% |
-10,609,978![]() (-100.00%) |
Filing History |
2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Mereo BioPharma Group plc MREO |
Baker Bros. Advisors LP | 69,359,359 9.990% |
4,441,758![]() (+6.84%) |
Filing History |
2023-02-14 2:55 pm Purchase |
2022-12-31 | 13G | Mereo BioPharma Group plc MREO |
Rock Springs Capital Management LP | 31,224,485 5.340% |
25,638,864![]() (+459.02%) |
Filing History |
2023-02-13 5:48 pm Sale |
2022-12-31 | 13G | Mereo BioPharma Group plc MREO |
Vivo Capital IX, LLC | 3,761,947 3.100% |
-5,647,104![]() (-60.02%) |
Filing History |
2023-02-13 1:21 pm Sale |
2022-12-31 | 13G | Mereo BioPharma Group plc MREO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 36,822,190 5.900% |
-8,888,145![]() (-19.44%) |
Filing History |
2022-10-28 1:17 pm Unchanged |
2022-10-28 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 83,780,600 13.410% |
0 (Unchanged) |
Filing History |
2022-09-23 4:18 pm Unchanged |
2022-09-15 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 83,780,600 13.410% |
0 (Unchanged) |
Filing History |
2022-08-23 6:31 pm Purchase |
2022-08-19 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 83,780,600 14.320% |
1,507,790![]() (+1.83%) |
Filing History |
2022-06-14 10:21 am Purchase |
2022-06-13 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 82,272,810 14.070% |
5,480,185![]() (+7.14%) |
Filing History |
2022-06-09 08:00 am Purchase |
2022-06-09 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 76,792,625 13.129% |
1,792,625![]() (+2.39%) |
Filing History |
2022-05-26 5:29 pm Purchase |
2022-05-26 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 75,000,000 12.820% |
427,765![]() (+0.57%) |
Filing History |
2022-02-15 12:44 pm Purchase |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Rock Springs Capital Management LP | 5,585,621 5.130% |
5,585,621![]() (New Position) |
Filing History |